Omnicell Net Worth 2010-2024 | OMCL

Interactive chart of historical net worth (market cap) for Omnicell (OMCL) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Omnicell net worth as of May 03, 2024 is $1.38B.
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.384B $1.147B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.275B 19.92
Inspire Medical Systems (INSP) United States $7.566B 0.00
Axonics (AXNX) United States $3.433B 0.00
10x Genomics (TXG) United States $3.275B 0.00
IRhythm Technologies (IRTC) United States $3.194B 0.00
Azenta (AZTA) United States $2.979B 242.82
Olink Holding AB (publ) (OLK) Sweden $2.861B 0.00
Enovis (ENOV) United States $2.812B 20.84
Hims & Hers Health (HIMS) United States $2.412B 0.00
Privia Health (PRVA) United States $2.224B 98.63
Schrodinger (SDGR) United States $1.712B 0.00
Phreesia (PHR) United States $1.259B 0.00
Definitive Healthcare (DH) United States $0.828B 0.00
Standard BioTools (LAB) United States $0.728B 0.00
Fulgent Genetics (FLGT) United States $0.643B 0.00
Talkspace (TALK) United States $0.538B 0.00
Health Catalyst (HCAT) United States $0.383B 0.00
Pulmonx (LUNG) United States $0.378B 0.00
Clover Health Investments (CLOV) United States $0.344B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.326B 0.00
P3 Health Partners (PIII) United States $0.202B 0.00
Butterfly Network (BFLY) United States $0.196B 0.00
American Well (AMWL) United States $0.165B 0.00
Outset Medical (OM) United States $0.162B 0.00
Augmedix (AUGX) United States $0.133B 0.00
MSP Recovery (LIFW) United States $0.125B 0.00
TruBridge (TBRG) United States $0.125B 5.33
Mobile-health Network Solutions (MNDR) Singapore $0.108B 0.00
111 (YI) China $0.096B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.053B 0.00
Movano (MOVE) United States $0.046B 0.00
EUDA Health Holdings (EUDA) Singapore $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.034B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.016B 0.00
Strata Skin Sciences (SSKN) United States $0.015B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00